Nifty Pharma defies mkt slump, up 1% as select drugs exempt from US tariffs

How 1 sources are covering this

• Business StandardCenter·2h ago

  Nifty Pharma defies mkt slump, up 1% as select drugs exempt from US tariffs

  Qualifying speciality medicines from India will be eligible for zero duty, providing some relief to Indian drugmakers with exposure to the US market.

  Read at Business Standard →